Skandinaviska Enskilda Banken (SEB)’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-38,186
Closed -$3.76M 792
2025
Q2
$3.76M Buy
38,186
+400
+1% +$37.8K 0.02% 478
2025
Q1
$3.5M Hold
37,786
0.02% 485
2024
Q4
$3.42M Hold
37,786
0.02% 476
2024
Q3
$3.65M Buy
37,786
+11,500
+44% +$1.12M 0.02% 474
2024
Q2
$2.41M Buy
26,286
+8,000
+44% +$742K 0.01% 519
2024
Q1
$1.69M Sell
18,286
-9,425
-34% -$883K 0.01% 607
2023
Q4
$2.63M Buy
27,711
+13,711
+98% +$1.28M 0.02% 523
2023
Q3
$1.31M Buy
+14,000
New +$1.29M 0.01% 637
2021
Q4
Sell
-400
Closed -$60K 998
2021
Q3
$60K Sell
400
-1,400
-78% -$291K ﹤0.01% 974
2021
Q2
$441K Sell
1,800
-5,400
-75% -$1.42M ﹤0.01% 895
2021
Q1
$1.91M Buy
7,200
+5,600
+350% +$1.58M 0.01% 674
2020
Q4
$469K Buy
+1,600
New +$410K ﹤0.01% 921

Other funds holding AMED

Skandinaviska Enskilda Banken (SEB)'s AMED Position: Q3 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Amedisys (AMED) in Q3 2025, closing a stake of 38,186 shares — an estimated $3.76M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in AMED in Q4 2020 and held it in 12 quarters. The position peaked at $3.76M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 38,186 Amedisys shares in Q3 2025, an estimated $3.76M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Amedisys in Q4 2020 and held it in 12 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Amedisys position peaked at $3.76M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2025, filed 7 Nov 2025.